Addyi

Cosette buys female libido drug Vyleesi from Palatin

Cosette has bought struggling female libido drug Vyleesi from Palatin for $12 million up front and $159 million in contingent, sales-based milestones.

Kevin Dunleavy Dec 20, 2023 11:53am

Sprout wants women to think pink when it comes to treating HSDD

Mar 16, 2022 12:00pm

Sprout's female libido drug Addyi back in FDA crosshairs

Jul 14, 2021 11:33am

Could AMAG’s Vyleesi be the ‘female Viagra’ that Addyi never was?

Jun 21, 2019 5:40pm

Sprout's old CEO is back with new Addyi marketing ideas

Jun 12, 2018 11:53am

Valeant trades $1B for 6% royalty on a drug that's not selling

Nov 6, 2017 11:16am